ACELYRIN, INC. - Common Stock (SLRN)
2.5000
-0.1900 (-7.06%)
Acelyrin Inc is a biopharmaceutical company focused on developing innovative therapies for patients with chronic and debilitating conditions
The company specializes in advancing treatments that target unmet medical needs, with particular emphasis on autoimmune and inflammatory diseases. Through its robust pipeline, Acelyrin aims to improve the quality of life for patients by harnessing cutting-edge science and technology to create effective and safe therapeutic options. The organization is committed to rigorous clinical research and collaboration with healthcare professionals to bring new solutions to the market.
Frequently Asked Questions
Is ACELYRIN, INC. - Common Stock publicly traded?
Yes, ACELYRIN, INC. - Common Stock is publicly traded.
What exchange does ACELYRIN, INC. - Common Stock trade on?
ACELYRIN, INC. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ACELYRIN, INC. - Common Stock?
The ticker symbol for ACELYRIN, INC. - Common Stock is SLRN on the Nasdaq Stock Market
What is the current price of ACELYRIN, INC. - Common Stock?
The current price of ACELYRIN, INC. - Common Stock is 2.500
When was ACELYRIN, INC. - Common Stock last traded?
The last trade of ACELYRIN, INC. - Common Stock was at 3:55 pm EST on March 4th, 2025